GRP
AUPH icon

Global Retirement Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Global Retirement Partners’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.9K Buy
+2,410
New +$38.5K ﹤0.01% 2653
2025
Q4 		$36.4K Hold
2,280
– – ﹤0.01% 2543
2025
Q3 		$25.2K Hold
2,280
– – ﹤0.01% 2285
2025
Q2 		$19.3K Buy
+2,280
New +$18.3K ﹤0.01% 2308
2024
Q4 		$20.5K Sell
2,280
-150
-6% -$1.22K ﹤0.01% 2072
2024
Q3 		$17.8K Hold
2,430
– – ﹤0.01% 2046
2024
Q2 		$13.9K Hold
2,430
– – ﹤0.01% 2165
2024
Q1 		$12.2K Sell
2,430
-100
-4% -$678 ﹤0.01% 2032
2023
Q4 		$19.7K Sell
2,530
-300
-11% -$2.47K ﹤0.01% 1764
2023
Q3 		$20.3K Sell
2,830
-10
-0.4% -$98 ﹤0.01% 1643
2023
Q2 		$27.5K Sell
2,840
-135
-5% -$1.4K ﹤0.01% 1532
2023
Q1 		$34.8K Sell
2,975
-250
-8% -$2.2K ﹤0.01% 1396
2022
Q4 		$13.9K Sell
3,225
-500
-13% -$2.9K ﹤0.01% 1632
2022
Q3 		$30K Hold
3,725
– – ﹤0.01% 1199
2022
Q2 		$37K Hold
3,725
– – ﹤0.01% 1107
2022
Q1 		$42K Sell
3,725
-600
-14% -$9.27K ﹤0.01% 1058
2021
Q4 		$99K Buy
+4,325
New +$102K 0.08% 75

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Global Retirement Partners's AUPH Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 2,410 shares worth $40.9K. The stake represents ﹤0.01% of the portfolio and ranks #2653 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AUPH as recently as Q4 2025.

Global Retirement Partners first reported a position in AUPH in Q4 2021 and has held it in 17 quarters since. The position peaked at $99K in Q4 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Global Retirement Partners held 2,410 shares of Aurinia Pharmaceuticals worth $40.9K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #2653 holding.
  • Global Retirement Partners first reported a position in Aurinia Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • Global Retirement Partners's Aurinia Pharmaceuticals position peaked at $99K in Q4 2021.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.